Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT00262925
Brief Title: Combination Chemotherapy and Alemtuzumab in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia

First Submitted : December 6, 2005
First Submitted that Met QC Criteria : December 6, 2005
First Posted : December 7, 2005 (Estimate)

Results First Submitted : April 25, 2014
Results First Submitted that Met QC Criteria : April 25, 2014
Results First Posted : May 23, 2014 (Estimate)

Last Update Submitted that Met QC Criteria : April 14, 2015
Last Update Posted : May 5, 2015 (Estimate)